Media Summary: How to Choose a CRO for Antibody Discovery Rheumatologist Joerg Ermann, MD, discusses In today's pharma landscape, patient convenience and drug delivery innovation go hand in hand. But how do you deliver ...

Biologics Brief Episode 1 - Detailed Analysis & Overview

How to Choose a CRO for Antibody Discovery Rheumatologist Joerg Ermann, MD, discusses In today's pharma landscape, patient convenience and drug delivery innovation go hand in hand. But how do you deliver ... In this video, I talk about a recent experience with a chest infection whilst immunosuppressed on This animation describes the differences between small molecule drugs and Watch this NHLBI Small Biz Hangout webinar to learn about the process of developing a new

The management of patients with Chronic Rhinosinusitis with Nasal Polyps (or CRSwNP) has been subject to a major revolution ... The Rheumatology Highlights Report Series is designed for the busy clinician and provides highlights from key scientific ... Join us as we take you behind the scenes of LOTTE The Impact of Biosimilars in Canada: A discussion between Dr. Vipul Jairath (University of Western Ontario) and Dr. John Marshall ... Fast-tracking development with earlier and better product and regulatory awareness. Biosimilar industry expert Dr. Fiona Greer is ...

Photo Gallery

Biologics Brief Episode 1
USMLE-Rx Express Video of the Week: Biologic Agents
Episode #1: Making Sense of Skin - Biologics in Dermatology
Biologic and Biosimilar Medications: Part 1
Episode 1 - Introduction to Biology
Biologic Drugs and Biosimilars
High Stakes, High Concentrations: Inside Biologics Innovation (Part 1)
Biologic Drugs in Rheumatology: What You Need to Know
Biologics in dermatology (Ahmad Kamel MD) part 1
The One Thing You Need To Know About Biologics
What is a biologic medication?
What Is a Biologic?
View Detailed Profile
Biologics Brief Episode 1

Biologics Brief Episode 1

How to Choose a CRO for Antibody Discovery |

USMLE-Rx Express Video of the Week: Biologic Agents

USMLE-Rx Express Video of the Week: Biologic Agents

Our Express Video of the Week covers

Episode #1: Making Sense of Skin - Biologics in Dermatology

Episode #1: Making Sense of Skin - Biologics in Dermatology

In this

Biologic and Biosimilar Medications: Part 1

Biologic and Biosimilar Medications: Part 1

Rheumatologist Joerg Ermann, MD, discusses

Episode 1 - Introduction to Biology

Episode 1 - Introduction to Biology

Welcome to

Biologic Drugs and Biosimilars

Biologic Drugs and Biosimilars

What are

High Stakes, High Concentrations: Inside Biologics Innovation (Part 1)

High Stakes, High Concentrations: Inside Biologics Innovation (Part 1)

In today's pharma landscape, patient convenience and drug delivery innovation go hand in hand. But how do you deliver ...

Biologic Drugs in Rheumatology: What You Need to Know

Biologic Drugs in Rheumatology: What You Need to Know

This video is all about the

Biologics in dermatology (Ahmad Kamel MD) part 1

Biologics in dermatology (Ahmad Kamel MD) part 1

understanding #dermatology #dr_ahmed_kamel #د_أحمد_كامل #dr_ahmad_kamel.

The One Thing You Need To Know About Biologics

The One Thing You Need To Know About Biologics

In this video, I talk about a recent experience with a chest infection whilst immunosuppressed on

What is a biologic medication?

What is a biologic medication?

Curious about how

What Is a Biologic?

What Is a Biologic?

This animation describes the differences between small molecule drugs and

Polyp Gossip - Episode 1: Surgical Whispers: Is One Surgery Enough Before Biologics?

Polyp Gossip - Episode 1: Surgical Whispers: Is One Surgery Enough Before Biologics?

Welcome to the debut

NHLBI Small Biz Hangout: Biologics Regulation Overview

NHLBI Small Biz Hangout: Biologics Regulation Overview

Watch this NHLBI Small Biz Hangout webinar to learn about the process of developing a new

Part 1 | CRSwNP: The Role of Biologics and Revision Surgery

Part 1 | CRSwNP: The Role of Biologics and Revision Surgery

The management of patients with Chronic Rhinosinusitis with Nasal Polyps (or CRSwNP) has been subject to a major revolution ...

Biologics UK 2023, part 1

Biologics UK 2023, part 1

This is the first

Update on Safety of Biologics - Ep. 1

Update on Safety of Biologics - Ep. 1

The Rheumatology Highlights Report Series is designed for the busy clinician and provides highlights from key scientific ...

LOTTE BIOLOGICS Documentary Part 1 : The Rise of LOTTE BIOLOGICS

LOTTE BIOLOGICS Documentary Part 1 : The Rise of LOTTE BIOLOGICS

Join us as we take you behind the scenes of LOTTE

Impact of Biosimilars in Canada Part 1: What have we learned so far?

Impact of Biosimilars in Canada Part 1: What have we learned so far?

The Impact of Biosimilars in Canada: A discussion between Dr. Vipul Jairath (University of Western Ontario) and Dr. John Marshall ...

Biosimilar Experts Roundtable: "Knowledge-based" Biologics Development- Part 1

Biosimilar Experts Roundtable: "Knowledge-based" Biologics Development- Part 1

Fast-tracking development with earlier and better product and regulatory awareness. Biosimilar industry expert Dr. Fiona Greer is ...